Billionaire Profile
F
Global Rank
#610

Image: Fischer, Albert, Edler von Zickwolff Franke, Willibald, 1871- | Public domain | via Wikimedia Commons

Franz von Baumbach

CEO, Pharma
GERMANY
Real-Time Net Worth
$6.506B
Estimated based on Pharma stock value as of March 6, 2026
0% (24h)
Age
24
Source
Pharma
Industry
Healthcare
Citizenship
GERMANY

Biography

Franz von Baumbach, a 24-year-old German citizen, is an heir to the Boehringer Ingelheim fortune, a leading name in the pharmaceutical industry. His source of wealth stems from his inherited stake in this privately-owned company, which was established in 1885. As part of the fourth generation of the von Baumbach family, Franz benefits from the legacy of Boehringer Ingelheim's success in developing and distributing innovative medicines for both humans and animals. While specific details about his career are limited, his presence on the Forbes list reflects the significant wealth associated with the family's involvement in the pharmaceutical sector.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Franz von Baumbach is part of a prominent German family with deep roots in the pharmaceutical industry. The von Baumbach family, along with the Boehringer and Liebrecht families, share the complete ownership of Boehringer Ingelheim. The company was founded in 1885.

Rise to Success

Franz von Baumbach's wealth comes from his inheritance in Boehringer Ingelheim, one of the world's largest privately-owned pharmaceutical companies. The company has a long history of innovation and has grown to have a presence in 130 markets, with 53,000 employees. Little is publicly known about his personal life or professional involvement in the company.

Key Business Strategies

The von Baumbach family has maintained a preference for privacy, and details about the business strategies employed by Franz are not publicly available. Boehringer Ingelheim is known for its long-term vision in medicine and its commitment to creating breakthrough therapies. The company's success is partly due to its focus on family and maintaining a good reputation.

Philanthropy

Information on Franz von Baumbach's specific philanthropic activities is not readily available. However, Boehringer Ingelheim, as a company, has been involved in initiatives to provide lower-priced HIV drugs and other health-related programs, indicating a commitment to social responsibility.

Career Milestones

Information not available

Inherited Stake in Boehringer Ingelheim

Inherited a stake in Boehringer Ingelheim, a major pharmaceutical company.

Philanthropy & Social Impact

Healthcare

Boehringer Ingelheim Initiatives

Information not available

Boehringer Ingelheim has been involved in initiatives to provide lower-priced HIV drugs and other health-related programs.

Business Philosophy & Leadership

Notable Quotes

"Information not available"

Leadership Principles

Information not available

Information not available

Controversies & Challenges

Information not available

Information not available

Information not available